NCT04050670View on ClinicalTrials.gov

A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 13, 2019

Primary Completion Date

April 3, 2020

Study Completion Date

April 3, 2020

Conditions
Healthy
Interventions
DRUG

Tirzepatide

Tirzepatide administered SC

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04050670 - A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes | Biotech Hunter | Biotech Hunter